journal cover

Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges

Nutrition and Cancer

Jan 1, 2016

Junxuan LüMaarten C Bosland

Get paper from

Abstract

The negative efficacy outcomes of double-blinded, randomized, placebo-controlled Phase III human clinical trials with selenomethionine (SeMet) and SeMet-rich selenized-yeast (Se-yeast) for prostate cancer prevention and Se-yeast for prevention of nonsmall cell lung cancer (NSCLC) in Nor...read more

Mentioned in this Paper

Selenium supplement
Double-Blind Method
Phase I/II Trial
Malignant Neoplasm of Prostate
Evaluation
Prostate Carcinoma
Non-Small Cell Lung Carcinoma
Clinical Trial [Publication Type]
Clinical Trials
Antioxidants
1
18
Paper Details
References
  • References91
  • Citations7
12345...

Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges

Nutrition and Cancer

Jan 1, 2016

Junxuan LüMaarten C Bosland

PMID: 26595411

DOI: 10.1080/01635581.2016.1105267

Abstract

The negative efficacy outcomes of double-blinded, randomized, placebo-controlled Phase III human clinical trials with selenomethionine (SeMet) and SeMet-rich selenized-yeast (Se-yeast) for prostate cancer prevention and Se-yeast for prevention of nonsmall cell lung cancer (NSCLC) in Nor...read more

Mentioned in this Paper

Selenium supplement
Double-Blind Method
Phase I/II Trial
Malignant Neoplasm of Prostate
Evaluation
1
18

Related Papers

Paper Details
References
  • References91
  • Citations7
12345...

Get paper from

/papers/cancer-chemoprevention-research-with-selenium-in/26595411